Pricing Log in Create free account

bioAffinity Technologies, Inc. (BIAF) vs ENDRA Life Sciences Inc. (NDRA)

bioAffinity Technologies, Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.7M against $5.1M — 1.5× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −257.3%) and the lower return on invested capital (−539.9% vs −408.7%). Across the 16 metrics below, ENDRA Life Sciences Inc. leads on 11 and bioAffinity Technologies, Inc. on 5.

Valuation

Metric BIAF NDRA Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.22 17.54 4.37
P/B 0.35 0.99 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA 0.05 n/m 24.35
EV/Sales (0.10) 2.22 5.51
Earnings yield (2,934.19%) (133.33%) (1.89%)
Free cash flow yield (889.05%) (124.95%) (0.15%)

Profitability

Metric BIAF NDRA Diagnostics & Research median
Gross margin 34.61% 0.00% 50.89%
Operating margin (209.82%) 0.00% (8.57%)
Net margin (257.33%) 0.00% (6.37%)
Free cash flow margin (195.90%) 0.00% 0.00%
Return on equity (1,860.15%) (152.04%) (2.92%)
Return on assets (245.51%) (110.08%) (6.71%)
Return on invested capital (408.67%) (539.89%) 0.00%

Growth

Metric BIAF NDRA Diagnostics & Research median
Revenue growth (TTM) (23.18%) — 7.69%
EPS growth (last fiscal year) 61.55% 84.32% 25.92%
Revenue growth, 5-year CAGR — — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIAF NDRA Diagnostics & Research median
Debt to equity 0.15 0.00 0.11
Current ratio 1.44 7.10 2.02
Net debt to EBITDA 0.57 0.14 0.70

Dividend

Metric BIAF NDRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BIAF NDRA Diagnostics & Research median
Market cap 5.08m 7.65m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack